STUDY SEARCH RESULTS

1 study found for your search request:  V114-036

Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036)
Condition: Pneumococcal disease
Minimum Age: 42 days, Maximum Age: 90 days
Gender: All
Study ID: NCT04633226
Status: Completed
Has Results




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site